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Validation of a novel device to objectively measure adherence to long-term
oxygen therapy
Abstract
Rationale: We have developed a novel oxygen adherence monitor that objectively measures patient use of
long-term oxygen therapy. The monitor attaches to the oxygen source and detects whether or not the
patient is wearing the nasal cannula.
Objective: The study's purpose was to validate the monitor's performance in patients with chronic
obstructive pulmonary disease during wakefulness and sleep.
Methods: Ten adult males with stable chronic obstructive pulmonary disease (mean ± SD FEV1 37.7 ±
14.9% of predicted) on long-term continuous oxygen therapy were tested in a sleep laboratory over a
12–13 hour period that included an overnight polysomnogram.
Measurements: The monitor's measurements were obtained at 4-minute intervals and compared to actual
oxygen use determined by review of time-synchronized video recordings.
Main results: The monitor made 1504/1888 (79.7%) correct detections (unprocessed data) across all
participants: 957/1,118 (85.6%) correct detections during wakefulness and 546/770 (70.9%) during sleep.
All errors were false negatives, i.e., the monitor failed to detect that the participant was actually wearing
the cannula. Application of a majority-vote filter to the raw data improved overall detection accuracy to
84.9%.
Conclusions: The results demonstrate the monitor's ability to objectively measure whether or not men
with chronic obstructive pulmonary disease are receiving their oxygen treatment. The ability to objectively
measure oxygen delivery, rather than oxygen expended, may help improve the management of patients on
long-term oxygen therapy.
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Rationale: We have developed a novel oxygen adherence monitor that objectively measures
patient use of long-term oxygen therapy. The monitor attaches to the oxygen source and detects
whether or not the patient is wearing the nasal cannula.
Objective: The study’s purpose was to validate the monitor’s performance in patients with
chronic obstructive pulmonary disease during wakefulness and sleep.
Methods: Ten adult males with stable chronic obstructive pulmonary disease (mean ± SD
FEV1 37.7 ± 14.9% of predicted) on long-term continuous oxygen therapy were tested in a sleep
laboratory over a 12–13 hour period that included an overnight polysomnogram.
Measurements: The monitor’s measurements were obtained at 4-minute intervals and compared to actual oxygen use determined by review of time-synchronized video recordings.
Main results: The monitor made 1504/1888 (79.7%) correct detections (unprocessed data)
across all participants: 957/1,118 (85.6%) correct detections during wakefulness and 546/770
(70.9%) during sleep. All errors were false negatives, ie, the monitor failed to detect that the
participant was actually wearing the cannula. Application of a majority-vote ﬁlter to the raw
data improved overall detection accuracy to 84.9%.
Conclusions: The results demonstrate the monitor’s ability to objectively measure whether
or not men with chronic obstructive pulmonary disease are receiving their oxygen treatment.
The ability to objectively measure oxygen delivery, rather than oxygen expended, may help
improve the management of patients on long-term oxygen therapy.
Keywords: chronic obstructive pulmonary disease

Long-term oxygen therapy (LTOT) is a well-established treatment for patients with
oxygen desaturation due to parenchymal lung diseases (NOT 1980; MRC 1981). In
patients with chronic obstructive pulmonary disease (COPD) and hypoxemia at rest,
continuous use of LTOT (⬎15 hours/day) improves survival and quality of life, and
reduces the number of hospitalizations (Criner 2000; Pierson 2000). Unfortunately,
this therapy is costly, accounting for approximately 30% (US $1.3 billion) of annual
Medicare expenditures for durable medical equipment (Dunne 2000). It is likely that
many of these dollars are wasted because studies report that many patients do not
adhere adequately to this treatment (Howard et al 1992; Granados et al 1997; Avdeev
et al 1999).
Compounding this problem, current methods used to measure adherence to LTOT
probably overestimate actual use. Each type of oxygen source used for LTOT requires
a different method to objectively assess patient adherence to treatment. For the oxygen
concentrator, average daily use is estimated by recording the concentrator’s hour-meter
readings (“power on” time) over a known period of time. For oxygen tanks, adherence is
estimated by knowing the prescribed ﬂow rate and the number of tanks used. For liquid
oxygen, adherence is calculated by weighing the container, knowing the ﬂow rate, and
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estimating the amount of evaporation and venting from the
system. All of the above measures are deﬁcient and probably
misleading because: 1) they do not discern whether or not the
patient is actually inhaling the oxygen, as opposed to merely
having the oxygen source turned on, ie, oxygen expenditure
may not reﬂect oxygen delivery to the patient, and 2) they fail
to provide information regarding the timing of oxygen use
within the day. The lack of an accurate, objective measure
of adherence to LTOT prevents the accurate determination
of the optimal duration of daily treatment. In addition, the
inability to identify patients with inadequate adherence prevents the development of interventions designed to improve
adherence and thereby to increase the effectiveness of this
expensive but life-saving treatment.
We have developed a novel oxygen adherence monitor to
address the above limitations and objectively document when
a patient is actually receiving oxygen treatment (Lin et al
2006). The monitor attaches to the oxygen source and detects
pressure in the tubing, including the respiratory-related pressure ﬂuctuations transmitted from the nares. The monitor is
designed to detect when the oxygen source is turned on and
when the patient is actually wearing the nasal cannula and
receiving treatment. Our monitor performs measurements
every four minutes over a 25-second duration and, for each
measurement, identiﬁes one of four conditions: source-on/
cannula-on, source-on/cannula-off, source-off/cannula-off,
and source-off/cannula-on. Periodic measurement, as opposed
to continuous measurement, was selected to extend battery life
of the AA battery powered monitor. The design and operating
characteristics of the device have been previously detailed and
the device has been validated in patients with COPD under
controlled conditions during relatively short periods while
sitting at rest and walking (Lin et al 2006). The purpose of
the current study was to evaluate the monitor’s performance
in patients with COPD during wakefulness and sleep over a
longer period of time and under less controlled conditions.
Some of the results of these studies have been previously
reported in the form of an abstract (Lin et al 2005).

Methods
Participant selection
Ten male adults with COPD using continuous LTOT via
nasal cannula were enrolled (Table 1). The participants were
recruited from veterans receiving care at the Philadelphia
Veterans Affairs Medical Center, where men constitute about
85% of the patient population.
COPD was identiﬁed as a forced expiratory volume in
one second (FEV1)/forced vital capacity (FVC) ⬍70% and

436

Table 1 Clinical characteristics of the 10 participants
Measure

Mean ± SD

Age (yr)

64 ± 7

Height (cm)

174.8 ± 4.3

Weight (kg)

94.3 ± 16.8

FEV1 (L)

1.19 ± 0.43

FEV1 (% predicted)

37.7 ± 14.9

FVC (L)

2.43 ± 0.73

FEV1/FVC (%)

59.6 ± 16.3

Abbreviations: FEV1, forced expiratory volume in one second; FVC, forced vital
capacity.

an FEV1 ⬍80% of predicted without signiﬁcant improvement following bronchodilator administration. None of the
participants had a previous diagnosis of sleep apnea or other
sleep disorder. The study was approved by the Institutional
Review Boards at the Philadelphia VAMC and the University
of Pennsylvania. Written informed consent was obtained
from all participants.

Oxygen adherence monitor
The oxygen adherence monitor (18 × 10 × 2 cm) was attached
by a “T” connection to the oxygen tubing near the oxygen
source (Lin et al 2006). The monitor consists of a pneumatic
ﬁltering system and an electronic detection system. The
pneumatic ﬁltering system isolates the ﬂuctuations in nasal
pressure from the oxygen supply pressure. The electronic
system consists of two pressure transducers, a microprocessor
used to sample the data coming from the pressure transducers, a memory storage chip, and a serial port to allow cable
connection for downloading data to a personal computer.
The microprocessor is programmed to identify four different
conditions (source-on/cannula-on, source-on/cannula-off,
source-off/cannula-off, and source-off/cannula-on), record
the exact time and date when each condition occurred, and
tabulate the total time spent in each condition.

Protocol
The participants arrived at the sleep center at 16:00 and
were administered supplemental oxygen at their prescribed
ﬂow rate (2–3 L/min) through a nasal cannula with a 50-ft
length of tubing attached to the wall oxygen supply in their
bedroom. Oxygen ﬂow rate remained constant throughout
the protocol. Therefore, the protocol tested two conditions:
source-on/cannula-off and source-on/cannula-on.
The participants were aware of the purpose of the study
and were instructed to remove the nasal cannula whenever

International Journal of COPD 2008:3(3)

Oxygen adherence monitor

they wished during wakefulness. Each participant performed
an overnight polysomnogram while wearing the oxygen
cannula. Prior to the start of the polysomnogram, they were
encouraged to watch TV, read magazines, and walk in their
bedroom. They were provided dinner between 18:00–19:00
and then changed into their bedtime clothes. Between
20:00–21:00, the sleep technologist attached the polysomnographic sensors while the participants sat in a chair. The
participants went to bed at their regular bedtimes, and the
polysomnograms were recorded using standard techniques
(AASM 1999).
Two wide-angle infrared cameras were placed in the
bedroom to determine whether or not the patient was wearing the oxygen cannula. Each camera was placed in an
opposite corner of the room to obtain the largest viewable
area. The video images from each camera were fed into a
single surveillance VCR (Lorex Technology Inc., Markham,
Ontario, Canada), that multiplexed the images from both
cameras and time-stamped the frames. White-colored paper
tags (1 × 2 inches) were placed on the nasal cannula tubing
at each cheek so that the cannula was clearly visible on the
video recording. Logs of the participants’ activities were kept
by the sleep technologists and were used to help interpret the
images on the videotape.
Throughout the protocol, the subjects wore an ultra-thin
nasal cannula with 4-foot length tubing securely taped to the
oxygen cannula to obtain simultaneous, continuous nasal
pressure recordings. During wakefulness, nasal pressure
was recorded using a light-weight, battery powered pressure
recorder (Stardust II, Respironics, Pittsburgh, PA, USA)
that hung around the neck. During the polysomnogram, the
ultra-thin nasal cannula was connected to a pressure transducer (Pro-Tech, Woodinville, WA, USA) with output to the
polysomnographic computer.
All time-sensitive devices used in the study were timesynched to the oxygen adherence monitor at the beginning
of the protocol.

Data analysis
The data from the oxygen adherence monitor were downloaded in text format for analysis. The polysomnograms were
manually scored with the aid of computer software by a certiﬁed polysomnographic technologist using standard guidelines
(ATS 1989; AASM 1999). All abnormal respiratory events
were at least 10 seconds in duration. Apneas were deﬁned
by an absence of airﬂow as evidenced by the nasal pressure
cannula signal. Hypopneas were deﬁned as a greater than
50% reduction in a respiratory signal from baseline, or a less
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than 50% reduction in a respiratory signal from baseline that
was associated with an arousal or an oxygen desaturation of
at least 3% (AASM 1999).
The monitor’s measurement (cannula “on” vs. cannula
“off”) from each sampling period was compared to the
same period of time on the videotape recording. Thirty out
of the total 1,918 measurements (⬍2%) occurred when the
participants were out of camera view and were excluded.
The accuracy of the monitor was assessed by computing the
percentage of the monitor’s measurements that were correct
relative to the videotape. The simultaneous, continuous nasal
pressure recordings were reviewed to evaluate possible explanations for any discrepancies between videotape and monitor,
eg, the videotape showing that the cannula was “on”, but the
monitor detecting the event as cannula “off ”.
Recognizing that the overall error contribution during
wakefulness and sleep was due to random false negatives, a
post-processing majority-vote ﬁlter was applied to the data
in an attempt to improve the accuracy of the monitor. The
majority-vote ﬁlter, sometimes referred to as a majority logical ﬁlter, is a standard digital analysis technique commonly
used to reduce noise in graphical data (Ting and Prasada
1980). The technique involves taking an odd-number of
contiguous sample points, each of which is designated as a
“1” or a “0”, counting up which value is more frequent (ie,
are there more “1’s” or more “0’s”?), and then assigning
the more frequent value to the center point of the collection.
Thus, the center point becomes a “1” if a majority of the data
points are “1’s.” This algorithm is then applied to all possible
same-size sample point collections in the data set.
In the present application, the majority-vote ﬁlter was
applied to each sequence of ﬁve successive sample points with
the “cannula-on” state designated as “1”, and the “cannula-off”
state as “0”. Thus, one can imagine the ﬁlter “moving along”
the time sequence of data points, taking ﬁve at a time, determining the majority for those ﬁve, and then shifting along
one time unit to process the next (overlapping) group of ﬁve
points. If the majority of measurements (ⱖ3) within a particular sequence indicated that the participant was wearing
the cannula, then the decision algorithm stipulated that the
cannula was “on”. If the majority of measurements indicated
that the patient was not wearing the cannula, then the decision
algorithm stipulated that the cannula was “off”.

Results
Each participant was monitored for at least 12 hrs (mean ±
SD = 12.9 ± 0.6). Time during wakefulness prior to the start
of the polysomnogram ranged from 3 to 6 hrs (5.0 ± 0.8) and
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polysomnogram duration ranged from 6 to 9 hrs (7.9 ± 0.8).
The polysomnographic results are presented in Table 2.
The mean total sleep time was 5.4 ± 1.8 hrs and the
mean sleep efficiency (total sleep time/recording time)
was 68.3% ± 23.5%. The mean apnea-hypopnea index was
18.5 ± 19.2 events/hr (range 2.0 to 63.1). All 8 patients
with an apnea-hypopnea index above 5 events/hr had
obstructive sleep apnea, and there was no evidence of
Cheyne-Stokes respiratory pattern. The apnea-hypopnea
index was ⬍5 events/hr in 2 participants, between 5
and 14.9 events/hr in 4 participants, between 15 and 29.9
events/hr in 2 participants, and 30 events/hr or greater in 2
participants. Minimum oxygen saturation was 86.4% ± 10.5%;
and only 0.6% ± 1.1% of the recording time was spent below
90% oxygen saturation.
Combining all data from the 10 participants, there were a
total of 1,888 measurements (1,118 during wakefulness and 770
during sleep) (Table 3). The oxygen adherence monitor detected
the correct condition in 1,504 measurements (unprocessed
data), yielding an overall raw detection accuracy of 79.7%.
The monitor made 957/1,118 (85.6%) correct detections during
wakefulness and 546/770 (70.9%) during sleep.
The monitor correctly detected all 47 measurements
that occurred when the participants were not wearing the
cannula, conﬁrming the 100% speciﬁcity described in
our previous validation study (Lin et al 2006). All errors
(161 during wakefulness and 223 during sleep) were false
negatives: ie, situations in which the monitor failed to
detect that the participant was actually wearing the cannula.
Prior to the polysomnogram recording, errors were more
common during rest than during activities such as eating,
talking, and dressing. Errors were more common during
REM compared to NREM sleep. Overall, 73.3% of the

Table 2 Results of polysomnogram (PSG) recordings
Measure

Mean ± SD

Total time monitored before PSG (hr)

5.0 ± 0.8

Total time monitored during PSG (hr)

7.9 ± 0.8

Total sleep time (hr)

5.4 ± 1.8

Time in NREM sleep (hr)

4.5 ± 1.8

Time in REM sleep (min)

47.3 ± 23.4

Sleep efficiency (%)

68.3 ± 23.5

Apnea/hypopnea index (events/hr)

18.5 ± 19.2

Mean O2 saturation (%)

97.5 ± 0.8

Minimum O2 saturation (%)

86.4 ± 10.5

Time O2 saturation ⬍90% (%)a

0.6 ± 1.1

Note: aPercent of total sleep time that oxygen saturation was ⬍90%.
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measurements were correct during NREM sleep whereas
only 57.3% of the measurements obtained in REM sleep
were correct.
Evaluating each individual’s results, the mean percentage
of accurate measurements over the entire recording period
was 79.3 ± 17.1%. Results varied widely across participants,
particularly during NREM and REM sleep (Table 3).
Mean detection accuracy was 85.5 ± 9.0% in wakefulness,
69.5% ± 34.6% in NREM sleep, and 63.6 ± 36.8% in REM
sleep. Individual detection accuracy in wakefulness was
below 80% in 2 of the participants. The monitor’s detection
accuracy was less than 80% in 5 of 10 participants during
NREM and REM sleep. Participants with the highest number
of detection errors were observed to have more frequent
episodes of diminished nasal pressure ﬂuctuations on the
simultaneous nasal pressure recording. On review of the false
negative detection errors, 94% could be explained by this
phenomenon. The remaining 6% of detection errors could
not be explained after reviewing the nasal pressure signals.
That is, a detection error occurred when the participant was
observed on the video recording to be wearing the cannula
and had clear nasal pressure signals on the simultaneous
nasal pressure recording during the monitor’s measurement
period.
There were no ﬁndings on routine history or physical
exam that identiﬁed those individuals in whom there was
lower detection accuracy during wakefulness. Figure 1
shows the relationship between the percentage of correct
measurements during sleep and the apnea-hypopnea index
in all participants.
The relationship across all participants was not signiﬁcant (R2 = 0.08, p ⬎ 0.05). However, when the two participants (participants 8 and 9) with a relatively low AHI and
low percentage of correct measurements during sleep were
removed from the analysis, a signiﬁcant negative correlation was present in the remaining 8 participants (R2 = 0.93,
p ⬍ 0.001). In contrast to the remaining eight participants,
the 2 participants with the unusual results showed a signiﬁcant amount of relatively shallow respiratory-related
pressure ﬂuctuations on the simultaneous nasal pressure
recording during sleep, even when apneas and hypopneas
were absent.
Approximately half of the monitor’s measurements that
occurred in association with an apnea or hypopnea resulted
in a detection error. Those apneas and hypopneas that did
not extend over the entire measurement period often allowed
enough time for the monitor to detect at least 2 respiratoryrelated nasal pressure cycles, the minimum number required
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Table 3 Detection accuracy of the monitor during wakefulness and sleep
Participant

Wakefulness

NREM sleep

REM sleep

# Total

# Correct

% Correct

# Total

# Correct

% Correct

# Total

# Correct

% Correct

1

97

88

90.7

94

87

92.6

13

10

76.9

2

119

114

95.8

65

62

95.4

16

15

93.8

3

137

119

86.9

58

22

37.9

11

2

18.2

4

80

65

81.3

87

86

98.9

14

14

100

5

90

85

94.4

102

81

79.4

5

4

80.0

6

165

142

86.1

19

18

94.7

1

1

100

7

115

75

65.2

39

1

2.6

24

5

20.8

8

107

83

77.6

58

15

25.9

9

0

0

9

89

73

82.0

88

65

73.9

12

8

66.7

10

119

113

95.0

50

47

94.0

5

4

80.0

Total

1118

957

85.6

660

484

73.3

110

63

57.3

Mean

85.5

69.5

63.6

SD

9.0

34.6

36.8

Notes: Total # = total number of samples; # Correct = number of samples in which the monitor determined the correct conditions (ie, cannula-on and cannula-off); % Correct =
percentage of samples in which the monitor determined the correct conditions.

during a measurement to designate the “cannula-on”
condition (Figure 2).
The majority-vote ﬁlter was applied to measurements
obtained prior to and during the polysomnogram, the latter including both wakefulness and sleep periods due to
the frequent transitions between the two states during

the polysomnogram recordings. The majority-vote ﬁlter
improved the monitor’s overall detection accuracy, over the
entire recording period, to 84.9% (Table 4).
Without the ﬁlter, ie, unprocessed data, the mean accuracy
across participants was 86.2 ± 9.8% prior to the polysomnogram and 75.2 ± 22.5% during the polysomnogram. When

120

Accuracy (% correct)

100
2

R = 0.93
80
2

R = 0.08

60
40
20
0
0

10

20

30

40

50

60

70

AHI (events/hr)
Figure 1 Percent of correct measurements with the oxygen adherence monitor versus apnea-hypopnea index (AHI) during sleep in all ten participants. The square markers
represent the two participants in whom there were a high number of incorrect measurements despite a relatively low AHI. Regression lines are shown for data including all
participants (solid line, R2 = 0.083) and data excluding two of the subjects (dashed line, excluding square markers, R2 = 0.93, p ⬍ 0.001).
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Figure 2 Nasal pressure recordings during sleep in two participants who were wearing nasal cannula.The recording in the upper panel reveals repetitive apneas in an individual
during NREM sleep. The prolonged period of absent and markedly attenuated nasal pressure signal in the recording in the lower panel occurred in another participant during
REM sleep. The solid bars indicate the time that the oxygen adherence monitor obtained one of its 25 second samples. The sample in the upper panel occurred near the end
of an apnea; and there were a sufficient number of respiratory-related pressure fluctuations for the monitor to correctly detect that the participant was wearing the cannula.
In the lower panel, the pressure fluctuations during the sampling period were of insufficient amplitude; and the monitor incorrectly determined that the participant was not
wearing the cannula.

Discussion

the majority-vote ﬁlter was applied to these data, the mean
detection accuracy rose to 90.8 ± 14.4% prior to the polysomnogram and 81.2 ± 26.5% during the polysomnogram.
Application of the ﬁlter improved detection accuracy in 9 of
the 10 participants before the polysomnogram and in 8 of the
10 participants during the polysomnogram.

The results demonstrate the ability of our oxygen adherence monitor to objectively measure whether or not
patients with COPD are receiving their oxygen treatment.
The monitor’s accuracy in detecting whether or not the
participants were wearing the nasal cannula, without

Table 4 Effect of applying a majority-vote filter on the percentage of the monitor’s correct determinations*
Participant

Raw data

Majority vote filter

Before PSG

During PSG

Total

Before PSG

During PSG

Total

1

89.3

91.7

90.7

96.3

99.2

98.0

2

94.5

96.3

95.5

96.6

99.1

98.0

3

91.8

57.1

69.4

100

57.3

72.3

4

85.7

93.6

91.2

100

100

100

5

94.8

80.8

86.3

98.7

100

99.5

6

82.0

89.5

87

91.5

100

97.2

7

65.2

38.6

45.5

52.3

36.2

40.2

8

76.3

39.4

56.3

88.5

40.2

62.4

9

84.9

72.4

77.2

85.9

79.8

82.2

10

97.1

92.4

94.3

98.5

100

99.4

Mean

86.2

75.2

79.3

90.8

81.2

84.9

SD

9.8

22.5

17.1

14.4

26.5

20.6

Notes: *Correct determinations = (number of samples correctly identified as cannula-on or cannula-off/total number of samples).
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post-processing, was 79.3% ± 17.1%. Mean detection
accuracy was 85.5% ± 9.0% in wakefulness, 69.5 ± 34.6%
in NREM sleep, and 63.6% ± 36.8% in REM sleep. All errors
were due to the monitor failing to detect that the participant
was actually wearing the cannula. In 8 of the 10 subjects,
the percentage of detection errors during sleep appeared to
be directly related to the apnea-hypopnea index. The overall
detection accuracy of 79.7% using the raw data improved to
84.9% with application of a post-processing majority-vote
ﬁlter.
The results extend our previous study by testing the
monitor’s performance during different activities of daily
living and sleep in patients with COPD (Lin et al 2006). In
our previous study, we used direct observation to validate the
monitor’s performance in patients with COPD. In contrast
to the current study, that previous study consisted of a
relatively brief protocol, lasting about 1 hour, during periods
of sitting and walking that were precisely timed so that the
transitions between the different conditions did not occur
when the monitor was making a measurement. In addition,
the previous study was performed using nasal cannula
with a 6-foot length of tubing. Under those circumstances,
the monitor had an overall 86% sensitivity (ie, correctly
detecting that the cannula were on) and 100% speciﬁcity (ie
correctly detecting that the cannula were off). The current
study tested the monitor’s performance over a longer period
of time during both wakefulness and sleep using 50-ft
length nasal cannula, and under less controlled conditions
than our previous study (Lin et al 2006). The subjects were
free to perform their usual activities of daily living during
wakefulness. The results of the current study indicate that
the monitor is able to detect the presence or absence of
respiratory-related pressure ﬂuctuations at the nares during
wakefulness and sleep even when positioned at the end a
50-ft. length of tubing, the standard length used at home by
patients on LTOT.
In the current study, patients were observed simultaneously
by three methods: oxygen adherence monitor, video-recording, and continuous nasal pressure recordings. The videorecording served as our “direct observation” to document
whether or not the participant was wearing the cannula. These
observations allowed us to determine the accuracy of the oxygen adherence monitor. The nasal pressure recordings allowed
us to evaluate discrepancies between the oxygen monitor and
the video-recording, ie, to differentiate between the technical
(ability of the monitor to sense the pressure ﬂuctuations at the
nares) and methodological (actual presence of signiﬁcant nasal
pressure ﬂuctuations) causes of the discrepancies.
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The technical assessment relates to the monitor’s ability to
detect respiratory-related pressure ﬂuctuations in the cannula
supply line. These small pressure ﬂuctuations from the nares
are superimposed on a much larger oxygen supply pressure
delivered at the proximal end of a long tube, and then detected
through a microprocessor-controlled electropneumatic
device. In principle, limitations in the design, construction,
and use of the monitor might result in inaccurate detection
of breathing. For example, if inspection of the nasal pressure recording showed that there was a good nasal pressure
signal, but the monitor did not detect this breathing signal,
then we would conclude that there was a technical limitation.
A review of the continuous nasal pressure recordings at the
time of almost all incorrect measurements showed that the
pressure signal during these sampling periods were, in fact,
very shallow or virtually ﬂat, indicating that the monitor’s
inability to correctly detect when the cannula was “on” was
due to the method used to assess adherence rather than the
monitor’s technical performance.
Even if the monitor works perfectly from a technical
standpoint, it may still make incorrect observations in subjects who do not breathe normally through the nose. We
deﬁned “oxygen use” in terms of the presence of respiratoryrelated pressure ﬂuctuations at the nares. We recognize the
possibility that these pressure ﬂuctuations may be absent even
though the nasal cannula are placed correctly in the nares.
Pharyngeal airway closure during sleep, mouth breathing, and
nasal airway obstruction might result in little or no respiratory-related pressure variations at the nares. For example, a
shift from nasal to oral breathing might be associated with
closure of the retropalatal oropharynx, damping transmission of airway pressure into the nasal passage (Thurnheer
et al 2001). Under such circumstances, our device might not
sense nasal breathing even when the subject was wearing the
cannula and would incorrectly indicate that the subject was
not adhering to treatment. This appears to be the explanation
for many of the detection errors during sleep. Measurement
errors tended to be more common in participants with a
higher apnea-hypopnea index, and apneas and hypopneas are
associated with absent or relatively low respiratory-related
nasal pressure ﬂuctuations. Since the monitor depends on
the presence of respiratory-related ﬂuctuations to determine if the patient is using the cannula, the lack of these
ﬂuctuations explains why the monitor incorrectly indicated
that the cannula was not being worn. Increasing the length
of the sample period or the sampling frequency might help
reduce the monitor’s detection errors in the presence of sleep
disordered breathing.
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Six percent of detection errors could not be explained
after reviewing the nasal pressure signals. That is, a detection
error occurred when the patient was directly observed to
be wearing the cannula and the continuous nasal pressure
recording showed adequate respiratory-related pressure
ﬂuctuations. The most likely explanation is that the continuous nasal pressure recordings during those periods may not
have fully represented the signals that were analyzed by the
monitor. For example, the oxygen delivery tube could have
been slightly compressed during a measurement but the nasal
pressure recording tube was undisturbed. The monitor’s
pneumatic ﬁltering system is sensitive to sharp pressure
increases that cause the incoming pressure signal to be out
of detection range. In these cases, the monitor detects that
the patient is not wearing the cannula. A situation in which
this might occur could be when the patient is turning in his
sleep and partially resting on the oxygen delivery tube.
In summary, the results further validate the use of a novel
monitor to objectively document patient adherence to LTOT.
The monitor was most accurate in detecting when participants
were not wearing the cannula, yielding 100% speciﬁcity.
Excellent results were also obtained when participants were
awake and performing daily activities. The most difﬁcult
monitoring situation was observed during sleep, and results
indicate that accuracy may be reduced in participants who are
mouth breathers and/or have frequent apneas and hypopneas.
Processing the data with a majority-vote ﬁlter improved
detection accuracy. The monitor’s ability to objectively
measure oxygen delivery, rather than oxygen expended, and
determine daily patterns of oxygen use will provide valuable
information that may lead to new management strategies
designed to improve patient adherence to LTOT.
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